| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.36 | 1e-15 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.079 | 0.08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.073 | 0.08 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.042 | 0.4 |